QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), today announced financial results for its first quarter ended on October 31, 2024.
Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD) (OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to fibroinflammatory diseases, is pleased to ...
QUEBEC CITY, October 09, 2024--Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio ...
Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada where it owns a state-of-the art extraction facility with full traceability ‘from the seed to the pill’.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results